Browse News
Filter News
Found 115 articles
-
Genetic Testing Market Size to Set USD 64.73 Billion by 2033
4/8/2024
According to Vision Research Reports, the global genetic testing market size was estimated at around USD 8.84 billion in 2023 and it is projected to set around USD 64.73 billion by 2033 with a CAGR of 22.03% from 2024 to 2033.
-
Small Satellite (CubeSat) Launch Provider, Vector Space Biosciences, Announces New Drug Repurposing Platform Using Data Generated in Space
11/20/2023
Vector Space Biosciences, Inc., in collaboration with Oracle and NVIDIA, introduces the availability of its new small satellite launch platform for biotechnology and pharmaceutical companies.
-
Personalized Medicine Market Report Insight to 2030
8/9/2023
The global personalized medicine market size was exhibited at USD 2.12 trillion in 2021 and it is expected to be worth around USD 5.7 trillion by 2030 with a CAGR of 11.6% from 2022 to 2030.
-
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe
6/12/2023
SomaLogic, Inc., a leader in proteomics technology, announced their collaboration with Citogen, the Longwood Group’s customer services and support unit, to establish the company’s first authorized site in Spain.
-
13% CAGR, Neurological Biomarker Market Share to Gain $14+ Billion Revenue by 2027 | Exclusive Report by The Insight Partners
5/26/2023
According to The Insight Partners latest study on "Neurological Biomarker Market Size, Share, Growth, Trends and Forecast to 2027 – COVID-19 Impact and Global Analysis
-
Genetic Testing Market Size To Hold USD 15.80 Bn By 2030
12/7/2022
The global genetic testing market size was exhibited at USD 8.52 billion in 2022 and is expected to hold around USD 15.80 billion by 2030 growing at a CAGR of 5.25% from 2022 to 2030
-
Metabolomics Market Size 2022 to 2030- Quantitative Research By QYResearch Medical
11/11/2022
The global metabolomics market size was USD 1.88 Billion in 2020 and is expected to register a revenue CAGR of 13.2% during the forecast period.
-
BioAro launches its genomics and microbiome services, bringing ease of access and the most comprehensive health analysis of DNA to the North American public before its global expansion
10/18/2022
Calgary-based genomics and precision health company, BioAro, is launching its comprehensive genetic and microbiome testing services.
-
Nutrigenomics Market Size Worth USD 1,289.7 Million in 2028 | Emergen Research
9/13/2022
The global nutrigenomics market size is expected to reach USD 1,289.7 Million in 2028 and register a steady revenue CAGR over the forecast period, according to latest analysis by Emergen Research.
-
Vector Space Biosciences Announces New Tools for Developing Countermeasures Associated to Stressors During Spaceflight
8/18/2022
To establish a lunar base or go to Mars, understanding how to protect and repair the human body during spaceflight is imperative.
-
Metabolomics Market Size to Reach $6,663 Million by 2030
6/2/2022
The global metabolomics market size was accounted at $2,032 Million in 2020, and it is expected to reach $6,663 Million by 2030, registering a CAGR of 12.5% from 2021 to 2030.
-
Metabolomics Market Size 2022-2028- Increasing Funds For Research & Development In Pharmaceutical And Biotechnology Sector Is A Key Revenue Growth Driving Factor
5/17/2022
According to the latest report by Reports and Data, the global metabolomics market size was USD 1.88 Billion in 2020 and is expected to reach USD 5.10 Billion in 2028 and register a revenue CAGR of 13.2% during the forecast period, 2021-2028.
-
Dante Labs receives grant by Italian government to pilot revolutionary CE-IVD, clinical whole genome sequencing-based Citizen Test for a G7 country, starting a new era in clinical genomics
5/10/2022
Dante Labs , a global leader in genomics and precision medicine, is pleased to announce the Italian Ministry of Economic Development has selected Dante to develop and pilot the first fully-CE-IVD, clinically approved whole genome sequencing (WGS) test for the citizens of Italy to be named the Dante Citizen Test.
-
Predictive Genetic Testing and Consumer Wellness Genomics Market: Expand at a CAGR of 13.9% during the Forecast (2019-2025)
5/6/2022
The global predictive genetic testing and consumer/wellness genomics market is estimated to expand at a CAGR of 13.9% during the forecast period of 2019 to 2025.
-
Global Direct to Consumer DNA Test Kits Market 2028
4/8/2022
Home DNA Test Kit Market Opportunity Forecast 2028 Report Highlights.
-
Nutrigenomics Market Growth – at a CAGR of 16.2% During Forecast Period 2020-2028
4/4/2022
Increasing prevalence of nutritional deficiency disorders and growing awareness of health & wellness among the population are some of the key factors driving market revenue growth.
-
Home Direct to Consumer DNA Test Kit Market Insight 2028
3/29/2022
Genetic or DNA testing usually refers to medical tests that examine and evaluates the changes in chromosomes, genes, or several types of proteins to help a person's chance of developing one or rule out a suspected genetic condition.
-
Genetic Testing Market Size to Hit US$ 13.90 Billion by 2029
3/28/2022
The genetic testing market size is expected to hit US$ 13.90 billion by 2030 from valued at US$ 7.54 billion in 2020 with a CAGR of 7.6% over the forecast period 2021 to 2030.
-
Dante Labs establishes the first of its Regional Medical Genomics Boards in Europe made of national and multinational world leaders in genomics
3/24/2022
Dante Labs announces the establishment of the first of its Medical Genomics Boards, strengthening the Company’s mission and research activity in this new frontier of healthcare, using genomics to promote prevention and treatment.
-
Home DNA Test Kit Market USD 10 Billion Opportunity By 2028
3/22/2022
Global DNA Test Kit Market Opportunity > USD 10 Billion by 2028.